Skip to main content

Advertisement

SpringerLink
Log in

Natural history of hepatitis B virus infection: pediatric perspective

  • Review
  • Published:
Journal of Gastroenterology Aims and scope Submit manuscript

Abstract

Hepatitis B virus (HBV) infection is an important disease globally. Chronic HBV infection may result in serious complications. Its transmission may be either perinatal or horizontal. Perinatal transmission is particularly important after the implementation of a universal vaccination program. Through either route, chronic carrier status is usually established in early childhood. The course of the disease course is determined by the host–virus interaction. The host’s immune system initially tolerates the virus, and then gradually attempts to clear it. The virus, on the other hand, tries to avoid host immune system attack by a strategy involving targeted epitope mutations. By generating mutants, the virus can survive attacks from the host’s immune system, enabling the infection to persist. Different individuals have different responses to HBV infection; genetic polymorphisms in cytokines, hormones, and other immune modulators may affect the final outcome of chronic HBV infection. Due to the implementation of a universal infant HBV vaccination program, HBV infection is now under control. Unfortunately, there still are some cases of vaccination failure. Very high maternal viremia, in utero infection, or escape mutants are possible reasons for vaccination failure. Immunocompromised hosts also risk vaccination failure. Blood or organ donors with occult HBV infection are possible sources for immunocompromised hosts. These victims of vaccination failure may exhibit a different disease course due to chronic HBV infection from those who acquired the infection before the universal vaccination era. The achievement of our ultimate goal of HBV elimination depends on a globally effective universal vaccination program, as well as the application of some novel successful medications to control those who are already infected.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Beasley RP, Stevens CE. Epidemiology of hepatitis B virus infection in Taiwan. In: Sung JL, Yu JY, Wang TH, editors. Proceedings of the International Symposium on Hepatitis in Taipei. Taipei: Gastroenterologic Society of the Republic of China, pp. 1–10.

  2. Hsu HY, Chang MH, Chen DS, Lee CY, Sung JL. Baseline seroepidemiology of hepatitis B virus in children in Taipei, 1984: a study just before mass hepatitis B vaccination program in Taiwan. J Med Virol. 1986;18:301–7.

    Article  CAS  PubMed  Google Scholar 

  3. Stevens CE, Beasley RP, Tsui J, Lee WC. Vertical transmission of hepatitis B antigen in Taiwan. N Engl J Med. 1975;292:771–4.

    Article  CAS  PubMed  Google Scholar 

  4. Chang MH. Chronic hepatitis virus infection in children. J Gastroenterol Hepatol. 1998;13:541–8.

    Article  CAS  PubMed  Google Scholar 

  5. Chu CM. Toward control of hepatitis B in the Asia-Pacific Region—natural history of chronic hepatitis B virus infection adults with emphasis on the occurrence of cirrhosis and hepatocellular carcinoma. J Gastroenterol Hepatol. 2000;15:E25–30.

    Article  PubMed  Google Scholar 

  6. Yuen MF, Lai CL. Toward control of hepatitis B in the Asia–Pacific region—natural history of chronic hepatitis B virus infection. J Gastroenterol Hepatol. 2000;15:E20–4.

    Google Scholar 

  7. Hadziyannis SJ, Papatheodoridis GV. Hepatitis B e antigen-negative chronic hepatitis B: natural history and treatment. Semin Liver Dis. 2006;26:130–41.

    Article  CAS  PubMed  Google Scholar 

  8. Ni YH, Chang MH, Chen PJ, Tsai KS, Hsu HY, Chen HL, et al. Viremia profiles in children with chronic hepatitis B infection and spontaneous e antigen seroconversion. Gastroenterology. 2007;132:2340–5.

    Article  PubMed  Google Scholar 

  9. Chang MH, Hsu HY, Ni YH, Tsai KS, Lee PI, Chen PJ, et al. Precore stop codon mutant in chronic hepatitis B virus infection in children: its relation to hepatitis B seroconversion and maternal hepatitis B surface antigen. J Hepatol. 1998;28:915–22.

    Google Scholar 

  10. Ni YH, Chang MH, Hsu HY, Tsuei DJ. Longitudinal study on mutation profiles of core promoter and precore regions of hepatitis B virus genome in children. Pediatr Res. 2004;56:396–9.

    Article  CAS  PubMed  Google Scholar 

  11. Ni YH, Chang MH, Hsu HY, Chen HL. Long-term follow-up study of core gene deletion mutants in children with chronic hepatitis B virus infection. Hepatology. 2000;32:124–8.

    Article  CAS  PubMed  Google Scholar 

  12. Ni YH, Chang MH, Hsu HY, Tung YC, Chen HL, Wang KJ, et al. Mutations of T cell epitopes on the hepatitis B virus surface gene in children with chronic infection and hepatocellular carcinoma. Am J Gastroenterol. 2008;103:1004–9.

    Article  CAS  PubMed  Google Scholar 

  13. Wu JF, Wu TC, Chen CH, Ni YH, Chen HL, Hsu HY, et al. Serum levels of interleukin 10 and 12 predict early, spontaneous hepatitis B virus e antigen seroconversion. Gastroenterology. 2010;138:165–72.

    Article  CAS  PubMed  Google Scholar 

  14. Wu JF, Tsai WY, Hsu HY, Ni YH, Chen HL, Tsuei DJ, et al. The effect of puberty onset on spontaneous hepatitis B virus e antigen seroconversion in men. Gastroenterology. 2010;138:942–8.

    Article  PubMed  Google Scholar 

  15. Liu CJ, Lo SC, Kao JH, Tseng PT, Lai MY, Ni YH, et al. Transmission of occult hepatitis B virus by transfusion to adult and pediatric recipients in Taiwan. J Hepatol. 2006;44:39–46.

    Article  PubMed  Google Scholar 

  16. Su WJ, Ho MC, Ni YH, Chen HL, Hu RH, Wu YM, et al. High-titer antibody to hepatitis B surface antigen before liver transplantation can prevent de novo hepatitis B infection. J Pediatr Gastroenterol Nutr. 2009;48:203–8.

    Article  CAS  PubMed  Google Scholar 

  17. Hsu C, Hsiung CA, Su IJ, Hwang WS, Wang MC, Lin SF, et al. A revisit of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in non-Hodgkin’s lymphoma: a randomized trial. Hepatology. 2008;47:844–53.

    Google Scholar 

  18. Loomba R, Rowley A, Wesley R, Liang TJ, Hoofnagle JH, Pucino F, et al. Systematic review: the effect of preventive lamivudine on hepatitis B reactivation during chemotherapy. Ann Intern Med. 2008;148:519–28.

    PubMed  Google Scholar 

  19. Chang MH, Chen THH, Hsu HM, Wu TC, Kong MS, Liang DC, et al. Prevention of hepatocellular carcinoma by universal vaccination against hepatitis B virus: the effect and problems. Clin Cancer Res. 2005;11:7953–7.

    Article  CAS  PubMed  Google Scholar 

  20. Beasley RP. Rocks along the road to the control of HBV and HCC. Ann Epidemiol. 2009;19:231–4.

    Article  PubMed  Google Scholar 

  21. Lok AS, McMahon BJ. Chronic hepatitis B. Hepatology. 2007;45:507–39.

    Article  CAS  PubMed  Google Scholar 

  22. Tang JR, Hsu HY, Lin HH, Ni YH, Chang MH. Hepatitis B surface antigenemia at birth: a long-term follow up study. J Pediatr. 1998;133:374–7.

    Article  CAS  PubMed  Google Scholar 

  23. Milich D, Liang TJ. Exploring the biological basis of hepatitis B e antigen in hepatitis B virus infection. Hepatology. 2003;38:1075–86.

    Article  CAS  PubMed  Google Scholar 

  24. Milich DR, Jones JE, Hughes JL, Price J, Raney AK, McLachlan A. Is a function of the secreted hepatitis B e antigen to induce immunologic tolerance in utero? Proc Natl Acad Sci USA. 1990;87:6599–603.

    Article  CAS  PubMed  Google Scholar 

  25. Hsu SC, Chang MH, Ni YH, Hsu HY, Lee CY. Horizontal transmission of hepatitis B virus in children. J Pediatr Gastroenterol Nutr. 1993;16:66–9.

    Article  CAS  PubMed  Google Scholar 

  26. Weinbaum CM, Williams I, Mast EE, Wang SA, Finelli L, Wasley A, et al. Recommendations for identification and public health management of persons with chronic hepatitis B virus infection. MMWR. 2008;57(RR08):1–20.

    PubMed  Google Scholar 

  27. Mast EE, Weinbaum CM, Fiore AE, Alter MJ, Bell BP, Finelli L, et al. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults. MMWR. 2006;55(RR16):1–25.

    PubMed  Google Scholar 

  28. Chang MH, Lee CY, Chen DS, Hsu HC, Lai MY. Fulminant hepatitis in children in Taiwan: the important role of hepatitis B virus. J Pediatr. 1987;111:34–9.

    Article  CAS  PubMed  Google Scholar 

  29. Hsu HY, Chang MH, Lee CY, Hsieh KH, Ni YH, Chen PJ, et al. Precore mutant of hepatitis B virus in childhood fulminant hepatitis B: an infrequent association. J Infect Dis. 1995;171:776–81.

    CAS  PubMed  Google Scholar 

  30. Chang MH, Hwang LY, Hsu HC, Lee CY, Beasley RP. Prospective study of asymptomatic HBsAg carrier children infected in the perinatal period: clinical and liver histologic studies. Hepatology. 1988;8:374–7.

    Article  CAS  PubMed  Google Scholar 

  31. Liaw YF, Chu CM. Hepatitis B virus infection. Lancet. 2009;373:582–92.

    Article  CAS  PubMed  Google Scholar 

  32. Ni YH, Huang LM, Chang MH, Yen CJ, Lu CY, You SL, et al. Two decades of universal hepatitis B vaccination in Taiwan: impact and implication for future strategies. Gastroenterology. 2007;132:1287–93.

    Article  PubMed  Google Scholar 

  33. Chang MH, Hsu HY, Hsu HC, Ni YH, Chen JS, Chen DS. The significance of spontaneous hepatitis B e antigen sero-conversion in childhood: with special emphasis on the clearance of hepatitis B e antigen before 3 years of age. Hepatology. 1995;22:1387–92.

    CAS  PubMed  Google Scholar 

  34. Chang MH, Sung JL, Lee CY, Chen CJ, Chen JS, Hsu HY, et al. Factors affecting clearance of hepatitis B e antigen in hepatitis B surface antigen carrier children. J Pediatr. 1989;115:385–90.

    Article  CAS  PubMed  Google Scholar 

  35. Chen YC, Chu CM, Liaw YF. Age-specific prognosis following spontaneous hepatitis B e antigen seroconversion in chronic hepatitis B. Hepatology. 2010;51:435–44.

    PubMed  Google Scholar 

  36. Bortolotti F, Guido M, Bartolacci S, Cadrobbi P, Crivellaro C, Noventa F, et al. Chronic hepatitis B in children after e antigen seroclearance: final report of a 29-year longitudinal study. Hepatology. 2006;43:556–62.

    Article  PubMed  Google Scholar 

  37. Liu J, Yang HI, Lee MH, Lu SN, Jen CL, Wang LY, et al. Incidence and determinants of spontaneous hepatitis B surface antigen seroclearance: a community-based follow-up study. Gastroenterology. 2010;139:474–82.

    Article  PubMed  Google Scholar 

  38. Chen CJ, Yang HI, Su J, Jen CL, You SL, Lu SN, et al. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA. 2006;295:65–73.

    Article  CAS  PubMed  Google Scholar 

  39. Wen WH, Chang MH, Hsu HY, Ni YH, Chen HL. The development of hepatocellular carcinoma among prospectively followed children with chronic hepatitis B virus infection. J Pediatr. 2004;144:397–9.

    Article  PubMed  Google Scholar 

  40. Chang MH, Chen PJ, Chen JY, Lai MY, Hsu HC, Lian DC, et al. Hepatitis B virus integration in hepatitis B virus-related hepatocellular carcinoma in childhood. Hepatology. 1991;13:316–20.

    Article  CAS  PubMed  Google Scholar 

  41. Liaw YF, Leung N, Kao JH, Piratvisuth T, Gane E, Han KH, et al. Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update. Hepatol Int. 2008;2:263–83.

    Article  PubMed  Google Scholar 

  42. Kao JH. Hepatitis B viral genotypes: clinical relevance and molecular characteristics. J Gastroenterol Hepatol. 2002;17:643–50.

    Article  CAS  PubMed  Google Scholar 

  43. Ni YH, Chang MH, Wang KJ, Hsu HY, Chen HL, Kao JH, et al. Clinical relevance of hepatitis B virus genotype in children with chronic infection and hepatocellular carcinoma. Gastroenterology. 2004;127:1733–8.

    Article  CAS  PubMed  Google Scholar 

  44. Kao JH, Chen PJ, Lai MY, Chen DS. Hepatitis B virus genotypes and spontaneous hepatitis B e antigen seroconversion in Taiwanese hepatitis B carriers. J Med Virol. 2004;72:363–9.

    Article  CAS  PubMed  Google Scholar 

  45. Hsu HY, Chang MH, Hsieh KH, Lee CY, Lin HH, Hwang LH, et al. Cellular immune response to HBcAg in mother-to-infant transmission of hepatitis B virus. Hepatology. 1992;15:770–6.

    Article  CAS  PubMed  Google Scholar 

  46. Rehermann B. Chronic infections with hepatotropic viruses: mechanisms of impairment of cellular immune responses. Semin Liver Dis. 2007;27:152–60.

    Article  CAS  PubMed  Google Scholar 

  47. Ganem D, Prince AM. Hepatitis B virus infection—natural history and clinical consequences. N Engl J Med. 2004;350:1118–29.

    Article  CAS  PubMed  Google Scholar 

  48. Lee WM. Hepatitis B virus infection. New Engl J Med. 1997;337:1733–45.

    Article  CAS  PubMed  Google Scholar 

  49. Carman WF, Fagan EA, Hadziyannis S, Karayiannis P, Tassopoulos NC, Williams R, et al. Association of a precore genomic variant of hepatitis B virus with fulminant hepatitis. Hepatology. 1991;14:219–22.

    Article  CAS  PubMed  Google Scholar 

  50. Nakahori S, Yokosuka O, Ehata T, Chuang WL, Imazeki F, Ito Y, et al. Detection of hepatitis B virus precore stop codon mutants by selective amplification method: frequent detection of precore mutants in hepatitis B e antigen positive healthy carriers. J Gastroenterol Hepatol. 1995;10:419–25.

    Article  CAS  PubMed  Google Scholar 

  51. Ni YH, Chang MH, Hsu HY, Tsuei DJ. Different hepatitis B virus core gene mutations in children with chronic infection and hepatocellular carcinoma. Gut. 2003;52:122–5.

    Article  CAS  PubMed  Google Scholar 

  52. Tordjeman M, Fontan G, Rabillon V, Martin J, Trepo C, Hoffenbach A, et al. Characterization of minor and major antigenic regions within the hepatitis B virus nucleocapsids. J Med Virol. 1993;41:221–9.

    Article  CAS  PubMed  Google Scholar 

  53. Raimondo G, Burk RD, Lieberman HM, Muschel J, Hadziyannis SJ, Will H, et al. Interrupted replication of hepatitis B virus in liver tissue of HBsAg carriers with hepatocellular carcinoma. Virology. 1988;166:103–12.

    Article  CAS  PubMed  Google Scholar 

  54. Liu CJ, Jeng YM, Chen CL, Cheng HR, Chen PJ, Chen TC, et al. Hepatitis B virus basal core promoter mutation and DNA load correlate with expression of hepatitis B core antigen in patients with chronic hepatitis B. J Infect Dis. 2009;199:742–9.

    Article  CAS  PubMed  Google Scholar 

  55. Chan HL, Hussain M, Lok AS. Different hepatitis B virus genotypes are associated with different mutations in the core promoter and precore regions during hepatitis B e antigen seroconversion. Hepatology. 1999;29:976–84.

    Article  CAS  PubMed  Google Scholar 

  56. Tai PC, Banik D, Lin GI, Pai S, Pai K, Lin MH, et al. Novel and frequent mutation of HBV coincide with a major histocompatibility complex class I-restricted T-cell epitope of the surface antigen. J Virol. 1997;71:4852–6.

    CAS  PubMed  Google Scholar 

  57. Kamatani Y, Wattanapokayakit S, Ochi H, Kawaguchi T, Takahashi A, Hosono N, et al. A genome-wide association study identifies variants in the HLA-DP locus associated with chronic hepatitis B in Asians. Nat Genet. 2009;41:591–5.

    Article  CAS  PubMed  Google Scholar 

  58. Yeh SH, Chiu CM, Chen CL, Lu SF, Hsu HC, Chen DS, et al. Somatic mutations at the trinucleotide repeats of androgen receptor gene in male hepatocellular carcinoma. Int J Cancer. 2007;120:1610–7.

    Article  CAS  PubMed  Google Scholar 

  59. Yu MW, Cheng SW, Lin MW, Yang SY, Liaw YF, Chang HC, et al. Androgen-receptor gene CAG repeats, plasma testosterone levels, and risk of hepatitis B-related hepatocellular carcinoma. J Natl Cancer Inst. 2000;92:2023–8.

    Google Scholar 

  60. Paz-y-Miño C, Witte T, Robles P, Llumipanta W, Díaz M, Arévalo M. Association among polymorphisms in the steroid 5alpha-reductase type II (SRD5A2) gene, prostate cancer risk, and pathologic characteristics of prostate tumors in an Ecuadorian population. Cancer Genet Cytogenet. 2009;189:71–6.

    Article  PubMed  Google Scholar 

  61. Yu MW, Yang YC, Yang SY, Cheng SW, Liaw YF, Lin SM, et al. Hormonal markers and hepatitis B virus-related hepatocellular carcinoma risk: a nested case-control study among men. J Natl Cancer Inst. 2001;93:1644–51.

    Article  CAS  PubMed  Google Scholar 

  62. Yeh SH, Chen PJ. Gender disparity of hepatocellular carcinoma: the roles of sex hormones. Oncology. 2010;78(Suppl 1):172–9.

    Article  CAS  PubMed  Google Scholar 

  63. Ni YH, Chang MH, Hsu HY, Hsu HC, Chen CC, Chen WJ, et al. Hepatocellular carcinoma in childhood. Cancer. 1991;68:1737–41.

    Article  CAS  PubMed  Google Scholar 

  64. Tsuei DJ, Hsu HC, Lee PH, Jeng YM, Pu YS, Chen CN, et al. RBMY, a male germ cell-specific RNA-binding protein, activated in human liver cancers and transforms rodent fibroblasts. Oncogene. 2004;23:5815–22.

    Article  CAS  PubMed  Google Scholar 

  65. Hsu HY, Chang MH, Ni YH, Lee PI. Cytokine release of peripheral blood mononuclear cells in children with chronic hepatitis B virus infection. J Pediatr Gastroenterol Nutr. 1999;29:540–5.

    Article  CAS  PubMed  Google Scholar 

  66. Hoofnagle JH. Reactivation of hepatitis B. Hepatology. 2009;49:S156–65.

    Article  CAS  PubMed  Google Scholar 

  67. Saab S, Waterman B, Chi AC, Tong MJ. Comparison of different immuno- prophylaxis regimens after liver transplantation with hepatitis B core antibody-positive donors: a systematic review. Liver Transplant. 2010;16:300–7.

    Google Scholar 

  68. Otte JB. History of pediatric liver transplantation. Where are we coming from? Where do we stand? Pediatr Transplant. 2002;6:378–87.

    Article  CAS  PubMed  Google Scholar 

  69. Su WJ, Ho MC, Ni YH, Wu JF, Jeng YM, Chen HL, et al. Clinical course of de novo hepatitis B infection after pediatric liver transplantation. Liver Transpl. 2010;16:215–21.

    Article  PubMed  Google Scholar 

  70. Marshall DA, Kleinman SH, Wong JB, AuBuchon JP, Grima DT, Kulin NA, et al. Cost-effectiveness of nucleic acid test screening of volunteer blood donations for hepatitis B, hepatitis C and human immunodeficiency virus in the United States. Vox Sang. 2004;86:28–40.

    Google Scholar 

  71. Ni YH, Chang MH, Huang LM, Chen HL, Hsu HY, Chiu TY, et al. Hepatitis B virus infection in children and adolescents in a hyperendemic area: 15 years after universal hepatitis B vaccination. Ann Intern Med. 2001;135:796–800.

    CAS  PubMed  Google Scholar 

  72. Carman WF, Zanetti AR, Karayiannis P, Waters J, Manzillo G, Tanzi E, et al. Vaccine-induced escape mutant of hepatitis B virus. Lancet. 1990;336:325–9.

    Article  CAS  PubMed  Google Scholar 

  73. Hsu HY, Chang MH, Ni YH, Chen HL. Survey of hepatitis B surface variant infection in children 15 years after nationwide vaccination program in Taiwan. Gut. 2004;53:1499–503.

    Article  PubMed  Google Scholar 

  74. Hsu HY, Chang MH, Ni YH, Chiang CL, Chen HL, Wu JF, et al. No increase in prevalence of hepatitis B surface antigen mutant in a population of children and adolescents who were fully covered by universal infant immunization. J Infect Dis. 2010;201:1192–200.

    Article  PubMed  Google Scholar 

  75. Chasela CS, Hudgens MG, Jamieson DJ, Kayira D, Hosseinipour MC, Kourtis AP, et al. Maternal or infant antiretroviral drugs to reduce HIV-1 transmission. N Engl J Med. 2010;362:2271–81.

    Article  CAS  PubMed  Google Scholar 

  76. van Zonneveld M, van Nunen AB, Niesters HG, de Man RA, Schalm SW, Janssen HL. Lamivudine treatment during pregnancy to prevent perinatal transmission of hepatitis B virus infection. J Viral Hepat. 2003;10:294–7.

    Article  PubMed  Google Scholar 

  77. Xu WM, Cui YT, Wang L, Yang H, Liang ZQ, Li XM, et al. Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double-blind, placebo-controlled study. J Viral Hepat. 2009;16:94–103.

    Article  PubMed  Google Scholar 

  78. Chang MH, Shau WY, Chen CJ, Wu TC, Kong MS, Liang DC, et al. Hepatitis B vaccination and hepatocellular carcinoma rates in boys and girls. JAMA. 2000;284:3040–2.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

The author thanks Prof. Mei-Hwei Chang for her critical review of this manuscript.

Author information

Authors and Affiliations

  1. Department of Pediatrics, College of Medicine and Children’s Hospital, National Taiwan University, 8 Chung-Shan South Road, Taipei, Taiwan

    Yen-Hsuan Ni

Authors
  1. Yen-Hsuan Ni
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yen-Hsuan Ni.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ni, YH. Natural history of hepatitis B virus infection: pediatric perspective. J Gastroenterol 46, 1–8 (2011). https://doi.org/10.1007/s00535-010-0304-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00535-010-0304-7

Keywords

Search

Navigation